Besides GLP-1 medications, several oral options are available for weight loss or can be prescribed off-label to assist patients in their weight-loss efforts
FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
When 5% of a practices prescriptions are compounded, thats manageable
The advisory notes these products are being marketed online and on social media for anti-aging, weight loss, injury recovery, sleep, mental focus and general wellness, and that Health Canada has already seized several of them
some models of how it formed predicted no core, while others showed it would have one
The management of pregnancies complicated by genital infections with herpes simplex virus